AIP
DMTK

Ameritas Investment Partners’s DermTech, Inc. Common Stock DMTK Stock Holding History

Ameritas Investment Partners’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,859
Closed -$27K – 3287
2022
Q1 		$27K Hold
1,859
– – ﹤0.01% 2429
2021
Q4 		$29K Hold
1,859
– – ﹤0.01% 2472
2021
Q3 		$60K Hold
1,859
– – ﹤0.01% 2040
2021
Q2 		$77K Buy
1,859
+1,143
+160% +$47K ﹤0.01% 1902
2021
Q1 		$36K Hold
716
– – ﹤0.01% 2283
2020
Q4 		$23K Hold
716
– – ﹤0.01% 2412
2020
Q3 		$9K Hold
716
– – ﹤0.01% 2780
2020
Q2 		$9K Buy
+716
New +$9.33K ﹤0.01% 2790

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return

Ameritas Investment Partners's DMTK Position: Q2 2022 in Review

Ameritas Investment Partners sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2022, closing a stake of 1,859 shares — an estimated $27K sold.

Ameritas Investment Partners first reported a position in DMTK in Q2 2020 and held it in 8 quarters. The position peaked at $77K in Q2 2021. 134 funds tracked by Wall St. Rank hold DMTK as of Q2 2022.

  • Ameritas Investment Partners reported no remaining DermTech, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Ameritas Investment Partners sold 1,859 DermTech, Inc. Common Stock shares in Q2 2022, an estimated $27K.
  • Ameritas Investment Partners first reported a position in DermTech, Inc. Common Stock in Q2 2020 and held it in 8 quarters.
  • Ameritas Investment Partners's DermTech, Inc. Common Stock position peaked at $77K in Q2 2021.
  • 134 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.